Does MEPOLIZUMAB Cause Increased bronchial secretion? 119 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Increased bronchial secretion have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.3% of all adverse event reports for MEPOLIZUMAB.
119
Reports of Increased bronchial secretion with MEPOLIZUMAB
0.3%
of all MEPOLIZUMAB reports
0
Deaths
65
Hospitalizations
How Dangerous Is Increased bronchial secretion From MEPOLIZUMAB?
Of the 119 reports, 65 (54.6%) required hospitalization.
Is Increased bronchial secretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Increased bronchial secretion?
ALBUTEROL (637)
OMALIZUMAB (144)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (93)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (87)
FLUTICASONE\SALMETEROL (86)
FLUTICASONE (82)
PREDNISONE (74)
TIOTROPIUM (65)
BUDESONIDE\FORMOTEROL (63)
CIPROFLOXACIN (55)
Which MEPOLIZUMAB Alternatives Have Lower Increased bronchial secretion Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE